Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $5.3 million.

  • Immunocore Holdings' Cash from Investing Activities rose 73429.95% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.0 million, marking a year-over-year increase of 9460.85%. This contributed to the annual value of -$355.1 million for FY2024, which is 644615.67% down from last year.
  • Latest data reveals that Immunocore Holdings reported Cash from Investing Activities of $5.3 million as of Q3 2025, which was up 73429.95% from -$30.4 million recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Cash from Investing Activities peaked at $9.7 million during Q1 2025, and registered a low of -$350.3 million during Q2 2024.
  • For the 5-year period, Immunocore Holdings' Cash from Investing Activities averaged around -$27.1 million, with its median value being -$985500.0 (2021).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 2501333.33% in 2024, then soared by 235627.91% in 2025.
  • Quarter analysis of 5 years shows Immunocore Holdings' Cash from Investing Activities stood at -$1.1 million in 2021, then plummeted by 80.05% to -$2.1 million in 2022, then surged by 60.3% to -$817000.0 in 2023, then crashed by 333.29% to -$3.5 million in 2024, then surged by 248.36% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, -$30.4 million for Q2 2025, and $9.7 million during Q1 2025.